Korro Bio and Genevant Sciences Enter into Collaboration Agreement to Develop RNA Editing Therapeutic for Alpha-1 Antitrypsin Deficiency Posted on 7th March 2023
Genevant Sciences and Arbutus Biopharma File Patent Infringement Lawsuit Against Moderna Posted on 28th February 2022
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases Posted on 23rd August 2021
Sarepta Therapeutics and Genevant Sciences to Collaborate for LNP-Based Gene Editing Therapeutics Posted on 13th January 202120th January 2021
